- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04280510
Pathogenic Study of Adult Immune Enteropathies (ENTEROPAH)
July 28, 2020 updated by: Institut National de la Santé Et de la Recherche Médicale, France
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases.
Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated.
Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Georgia MALAMUT, MD, PhD
- Phone Number: 33 1 58 41 41 76
- Email: georgia.malamut@aphp.fr
Study Contact Backup
- Name: Nadine CERF-BENSUSSAN, MD, PhD
- Phone Number: 33 1 42 75 42 88
- Email: nadine.cerf-bensussan@inserm.fr
Study Locations
-
-
-
Clichy, France, 92110
- Not yet recruiting
- Hopital Beaujon
-
Contact:
- Yoram Bouhnik, MD, PhD
- Email: yoram.bouhnik@aphp.fr
-
Principal Investigator:
- Yoram Bouhnik, MD, PhD
-
Sub-Investigator:
- Xavier Treton, MD, PhD
-
Créteil, France, 94010
- Not yet recruiting
- Hopital Henri Mondor
-
Contact:
- Iradj Sobhani, MD, PhD
- Email: iradj.sobhani@aphp.fr
-
Principal Investigator:
- Iradj Sobhani, MD, PhD
-
Sub-Investigator:
- Aurélien Amiot, MD, PhD
-
Le Kremlin Bicêtre, France, 94270
- Not yet recruiting
- Hôpital Bicêtre
-
Contact:
- Franck Carbonnel, MD, PhD
- Email: franck.carbonnel@aphp.fr
-
Principal Investigator:
- Franck Carbonnel, MD, PhD
-
Paris, France, 75012
- Not yet recruiting
- Hôpital Saint Antoine
-
Principal Investigator:
- Laurent Beaugerie, MD, PhD
-
Contact:
- Laurent Beaugerie, MD, PhD
-
Paris, France, 75014
- Recruiting
- Hopital Cochin
-
Contact:
- Georgia Malamut, MD, PhD
- Email: georgia.malamut@aphp.fr
-
Principal Investigator:
- Georgia MALAMUT, MD, PhD
-
Principal Investigator:
- Stanislas CHAUSSADE, MD, PhD
-
Sub-Investigator:
- Vered ABITBOL, MD, PhD
-
Paris, France, 75010
- Not yet recruiting
- Hôpital Saint Louis
-
Principal Investigator:
- Matthieu Allez, MD, PhD
-
Contact:
- Matthieu ALLEZ, MD, PhD
- Email: matthieu.allez@aphp.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients planned to have blood specimens and possible upper and/or lower digestive endoscopy.
Description
Inclusion Criteria:
- 18 years or over
- affiliated to social insurance
- signed informed consent
Exclusion Criteria:
- pregnancy
- under guardianship
- not able to sign informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Active coeliac patients
Patients with active coeliac disease
|
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
|
Treated coeliac patients
Patients with coeliac disease on gluten free diet
|
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
|
Sprue type I
Patients with refractory coeliac disease of type I
|
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
|
Sprue type II
Patients with refractory coeliac disease of type II
|
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
|
Intestinal Lymphoproliferations
Patients with intestinal lymphoproliferations
|
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
|
Non coeliac enteropathies
Patients with non coeliac immune-mediated enteropathy
|
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
|
Patients without neoplastic or inflammatory intestinal disease
|
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intestinal Lymphocytes count
Time Frame: Baseline
|
Lymphocytes isolation
|
Baseline
|
DNA sequencing
Time Frame: Baseline
|
Targeted Next Generation sequencing
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Georgia MALAMUT, MD, PhD, APHP, Université de Paris (Université Paris Descartes)
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 27, 2020
Primary Completion (Anticipated)
February 27, 2028
Study Completion (Anticipated)
February 27, 2028
Study Registration Dates
First Submitted
January 20, 2020
First Submitted That Met QC Criteria
February 20, 2020
First Posted (Actual)
February 21, 2020
Study Record Updates
Last Update Posted (Actual)
July 29, 2020
Last Update Submitted That Met QC Criteria
July 28, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C19-07
- 2019-A01594-53 (Registry Identifier: ID-RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Diseases
-
Centre Hospitalier Universitaire, AmiensFunding from DGOS (PHRC IR 2013 and PRME)CompletedPediatric Inflammatory Bowel DiseaseFrance
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University of Wisconsin, MadisonTerminatedInflammatory Bowel Disease (IBD)United States
-
Cedars-Sinai Medical CenterUnknownPediatric Inflammatory Bowel Disease
-
Assiut UniversityNot yet recruitingIBD-Inflammatory Bowel Disease
-
University of Wisconsin, MadisonCompletedInflammatory Bowel Disease (IBD)United States
-
Icahn School of Medicine at Mount SinaiNorthwestern University; The Cleveland Clinic; University of California, Davis; RxHealt...RecruitingInflammatory Bowel Disease (IBD)United States
-
Nemours Children's ClinicNASPGHAN FoundationCompletedInflammatory Bowel Disease (IBD)United States
-
Hull University Teaching Hospitals NHS TrustWellcome/EPSRC Centre for Interventional and Surgical Sciences, University...RecruitingInflammatory Bowel Disease 1United Kingdom
Clinical Trials on Blood sample collection; gastrointestinal biopsy
-
Institut Paoli-CalmettesCancer Research Center of MarseilleActive, not recruitingUrologic Neoplasms | Lung Cancer Metastatic | Non Hodgkin Lymphoma | Locally Advanced Malignant NeoplasmFrance
-
Kevin BruceNot yet recruiting
-
University of ManchesterThe Christie NHS Foundation TrustRecruiting
-
NYU College of DentistryActive, not recruiting
-
University of ArkansasActive, not recruitingHead and Neck Cancer | Lung CancerUnited States
-
Medical Neurogenetics, LLCUnited States Department of DefenseCompletedGulf War Syndrome | Mitochondrial DiseaseUnited States
-
Pichamol Jirapinyo, MD, MPHMayo Clinic; Tufts University; Boston Children's HospitalRecruitingHypertension | Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Cancer | Overweight | Gastroesophageal Reflux | Sleep Apnea | Hyperlipidemias | GERD | Obesity, Morbid | Overweight and Obesity | Overweight or Obesity | Diabetes Type 2 | Musculoskeletal Pain Disorder | Gastro-Intestinal Disorder | Obesity, PrimaryUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingPancreatic Cancer | Cancer CachexiaUnited States
-
University of MinnesotaCompletedCryptogenic Cirrhosis | Cryptogenic Chronic HepatitisUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); University of Miami; University of FloridaRecruitingPancreatic Cancer | Pancreatic CystUnited States